Skip to main content

Pluri Inc.

PLUR
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001158780

No open-market purchases or sales by Pluri Inc. insiders were filed in the last 90 days; 16 institutions reported holding it in 13F filings for Q2 2026, worth $55.3K in total; no superinvestor holds it.

Q1 2024 vs. Q4 2023

How the institutions holding Pluri Inc. changed between Q4 2023 and Q1 2024.

All holders in Q1 2024All holders in Q4 2023

13F holders of PLUR: Q4 2023 compared with Q1 2024
MeasureQ4 2023Q1 2024Change
Holders2623−3
Shares714.2K683.6K−30.6K (−4.3%)
Value$414.1K$563.0K+$148.9K (+36.0%)

New holders (4)

Institutions that held Pluri Inc. at the end of Q1 2024 but not at the end of Q4 2023.

Institutions new to PLUR in Q1 2024
InstitutionSharesValue% of portfolio
Raymond James Financial Services Advisors, Inc.38,645$31.1K0.00%
PFG Investments, LLC27,996$22.6K0.00%
Two Sigma Securities, LLC15,523$12.5K0.00%
Millennium Management LLC11,736$9.42K0.00%

Sold out (7)

Institutions that held Pluri Inc. at the end of Q4 2023 and filed for Q1 2024 without it.

Institutions that sold out of PLUR in Q1 2024
InstitutionShares, Q4 2023Value, Q4 2023
Bridgeway Capital Management, LLC52,600$30.5K
Virtu Financial LLC29,314$17.0K
Archford Capital Strategies, LLC13,091$7.59K
Altshuler Shaham Ltd2,520$1.46K
Royal Bank of Canada1,000$1.00K
TD Waterhouse Canada Inc.740$467
Qube Research & Technologies Ltd50$29